Evaluating and Improving Cancer Screening Process Quality in a Multilevel Context: The PROSPR II Consortium Design and Research Agenda

Author:

Beaber Elisabeth F.1ORCID,Kamineni Aruna2ORCID,Burnett-Hartman Andrea N.3ORCID,Hixon Brian3ORCID,Kobrin Sarah C.4ORCID,Li Christopher I.1ORCID,Oliver Malia2ORCID,Rendle Katharine A.5ORCID,Skinner Celette Sugg67ORCID,Todd Kaitlin1ORCID,Zheng Yingye1ORCID,Ziebell Rebecca A.2ORCID,Breslau Erica S.4ORCID,Chubak Jessica2ORCID,Corley Douglas A.8ORCID,Greenlee Robert T.9ORCID,Haas Jennifer S.10ORCID,Halm Ethan A.11ORCID,Honda Stacey12ORCID,Neslund-Dudas Christine13ORCID,Ritzwoller Debra P.3ORCID,Schottinger Joanne E.14ORCID,Tiro Jasmin A.67ORCID,Vachani Anil15ORCID,Doria-Rose V. Paul4ORCID

Affiliation:

1. 1Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.

2. 2Kaiser Permanente Washington Health Research Institute, Seattle, Washington.

3. 3Institute for Health Research, Kaiser Permanente Colorado, Aurora, Colorado.

4. 4Division of Cancer Control and Population Sciences, NCI, Bethesda, Maryland.

5. 5Departments of Family Medicine and Community Health and of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.

6. 6Department of Population & Data Sciences, University of Texas Southwestern Medical Center, Dallas, Texas.

7. 7Simmons Comprehensive Cancer Center, Dallas, Texas.

8. 8Division of Research, Kaiser Permanente Northern California, Oakland, California.

9. 9Center for Clinical Epidemiology & Population Health, Marshfield Clinic Research Institute, Marshfield, Wisconsin.

10. 10Division of General Internal Medicine, Massachusetts General Hospital, Boston, Massachusetts.

11. 11Department of Medicine, Robert Wood Johnson Medical School, New Brunswick, New Jersey.

12. 12Hawaii Permanente Medical Group, Kaiser Permanente Center for Integrated Health Care Research, Honolulu, Hawaii.

13. 13Department of Public Health Sciences, Henry Ford Health System, Detroit, Michigan.

14. 14Kaiser Permanente Bernard J Tyson School of Medicine, Pasadena, California.

15. 15Pulmonary, Allergy, and Critical Care Division, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.

Abstract

Abstract Background: Cancer screening is a complex process involving multiple steps and levels of influence (e.g., patient, provider, facility, health care system, community, or neighborhood). We describe the design, methods, and research agenda of the Population-based Research to Optimize the Screening Process (PROSPR II) consortium. PROSPR II Research Centers (PRC), and the Coordinating Center aim to identify opportunities to improve screening processes and reduce disparities through investigation of factors affecting cervical, colorectal, and lung cancer screening in U.S. community health care settings. Methods: We collected multilevel, longitudinal cervical, colorectal, and lung cancer screening process data from clinical and administrative sources on >9 million racially and ethnically diverse individuals across 10 heterogeneous health care systems with cohorts beginning January 1, 2010. To facilitate comparisons across organ types and highlight data breadth, we calculated frequencies of multilevel characteristics and volumes of screening and diagnostic tests/procedures and abnormalities. Results: Variations in patient, provider, and facility characteristics reflected the PROSPR II health care systems and differing target populations. PRCs identified incident diagnoses of invasive cancers, in situ cancers, and precancers (invasive: 372 cervical, 24,131 colorectal, 11,205 lung; in situ: 911 colorectal, 32 lung; precancers: 13,838 cervical, 554,499 colorectal). Conclusions: PROSPR II's research agenda aims to advance: (i) conceptualization and measurement of the cancer screening process, its multilevel factors, and quality; (ii) knowledge of cancer disparities; and (iii) evaluation of the COVID-19 pandemic's initial impacts on cancer screening. We invite researchers to collaborate with PROSPR II investigators. Impact: PROSPR II is a valuable data resource for cancer screening researchers.

Funder

NCI

NIH

Publisher

American Association for Cancer Research (AACR)

Subject

Oncology,Epidemiology

Reference56 articles.

1. Unifying screening processes within the PROSPR consortium: a conceptual model for breast, cervical, and colorectal cancer screening;Beaber;J Natl Cancer Inst,2015

2. Introduction: understanding and influencing multilevel factors across the cancer care continuum;Taplin;J Natl Cancer Inst Monogr,2012

3. A framework for improving the quality of cancer care: the case of breast and cervical cancer screening;Zapka;Cancer Epidemiol Biomarkers Prev,2003

4. American Medical Association [Internet] Chicago: The Association

Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3